Pharmaceutical development and GMP manufacturing capability

Vectura is able to apply our technologies to product development programmes through all stages of pharmaceutical and product development, including pivotal clinical trials and technical transfer to commercial production. Vectura has state-of-the-art development and Good Manufacturing Practice (GMP) facilities in Chippenham, UK, serving our requirements in both small molecule and biologic product spaces and following the merger with Skyepharma we have an additional GMP manufacturing suite in Muttenz, Switzerland. These facilities enable us to produce supplies for late-phase clinical trials using equipment that is entirely representative of that which would be used at the final commercial manufacturing site. This product development capability is supported by an extensive analytical capability generating the high quality data that is essential to the decision making required in product development.

Vectura lab work Vectura lab work

back to top